Product Images Darifenacin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Darifenacin NDC 62332-224 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medicine tablet. The tablet contains 17858 mg of arfbnecn-NG 62332-224-30 ctomide loprole 13 dfenacn B&o. The usual dosage is one tablet per day. The tablet has to be stored at 25°C (77°F) and excursions are permitted. The tablet is an extended-release type and measures 28x30mm. It is not to be taken by people who are not prescribed by the doctor as it is a prescription medicine. The manufacturer is Alembic Pharmaceuticals Limited. The address of the manufacturer is given below.*
Each tablet contains 8929 mg of Darifenacin and provides 75 mg of Darifenacin. The recommended dosage is one tablet daily. Darifenacin is an extended-release medication. Not available.*
This text is a table showing the mean plasma concentration of Darifenacin in ng/mL over a 24-hour period at different time points post-dose. The concentrations were measured in a group of individuals, including 95 EMs and 6 PMs for a 7.5mg dose and 104 EMs and 10 PMs for a 15mg dose.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.